Switzerland’s second-largest bank, Credit Suisse, is a defendant in a trial involving millions of euros that were allegedly laundered through its coffers by a Bulgarian drug trafficker.
This content was published on
2 minutes
swissinfo.ch/mga
Español
es
Credit Suisse se enfrenta a un juicio por blanqueo de dinero
The court case, which starts on Monday, has sparked fresh calls for increased scrutiny of the way banks do business in Switzerland.
Prosecutors state that the drug ring, headed by a former Bulgarian wrestler, washed CHF146 million ($158 million) through Credit Suisse, including large sums of cash in suitcases, between 2004 and 2008.
Two alleged members of the cocaine-smuggling ring and two former bankers, from Credit Suisse and Julius Bär, will be in the dock during the four-week trial.
Credit Suisse is also accused of playing a part in the alleged plot and is the first major Swiss bank to appear in a money-laundering trial in the country, says Swiss public broadcaster, SRF.
“Credit Suisse unreservedly rejects as meritless all allegations in this legacy matter raised against it and is convinced that its former employee is innocent,” the bank said in a statement to Reuters.
String of scandals
The court case is the latest in a string of scandals to hit Credit Suisse, which saw its chairman resign last month after ignoring Covid-19 restrictions.
Iran summons Swiss ambassador over US and Italy arrests
This content was published on
Iran has summoned the Swiss ambassador, who represents US interests, to protest against the arrest in the US and Italy of two Iranians.
Swisscom receives greenlight for acquisition of Vodafone Italia
This content was published on
The takeover of Vodafone Italia by Swisscom is nearing completion. All relevant authorities have now approved the €8 billion (CHF7.45 billion) deal.
Novo Nordisk stock market plunge drags down Swiss device maker Ypsomed
This content was published on
The Danish pharmaceutical giant, Novo Nordisk, faced setbacks on Friday that weighed on the share price of Swiss injection device manufacturer Ypsomed.
Swiss press react to EU deal with mix of euphoria and scepticism
This content was published on
Swiss media reaction to the agreement between Switzerland and the EU varies widely. Some are celebrating, while others worry about what is to come.
Swiss Solidarity donations to tackle child abuse top CHF4 million
This content was published on
Swiss Solidarity, the humanitarian arm of the Swiss Broadcasting Corporation (SBC), has raised over CHF4 million ($4.3 million) to tackle child abuse.
This content was published on
Switzerland is perceived as a relatively “clean” country when it comes to public sector corruption but it is not without problems.
Strip clubs and fraud: the trial of an unconventional Swiss banker
This content was published on
Fraud allegations against Raiffeisen's former CEO have raised questions over the governance of Switzerland's third largest bank.
Credit Suisse chair Horta-Osório resigns over Covid-19 breaches
This content was published on
Shares in Swiss bank Credit Suisse slipped on Monday after its chair António Horta-Osório quit following an internal probe.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.